Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease

Marcello Moccia, Sabina Pappatà, Marina Picillo, Roberto Erro, Anna Rita Daniela Coda, Katia Longo, Carmine Vitale, Marianna Amboni, Arturo Brunetti, Giuseppe Capo, Marco Salvatore, Paolo Barone, Maria Teresa Pellecchia

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Tremor dominant (TD) and akinetic-rigid type (ART) are two motor subtypes of Parkinson’s disease associated with different disease progression and neurochemical/neuropathological features. The role of presynaptic nigrostriatal dopaminergic damage is still controversial, poorly explored, and only assessed in medicated patients. In this study, we investigated with FP-CIT SPECT the striatal dopamine transporter (DAT) availability in drug-naïve PD patients with ART and TD phenotypes. Fifty-one de novo, drug-naïve patients with PD underwent FP-CIT SPECT studies. Patients were evaluated with Unified Parkinson’s Disease Rating Scale (UPDRS) part III and Hoehn and Yahr scale (H&Y) and divided into ART (24/51) and TD (27/51) according to UPDRS part III. ART and TD patients were not different with regard to age, gender, and disease duration. However, compared to TD, ART patients presented higher UPDRS part III (p = 0.01) and H&Y (p = 0.02) and lower DAT availability in affected and unaffected putamen (p = 0.008 and p = 0.007, respectively), whereas no differences were found in caudate. Moreover, in the whole group of patients, rigidity and bradykinesia, but not tremor scores of UPDRS part III were significantly related to FP-CIT binding in the putamen. These results suggest that in newly diagnosed drug-naïve PD patients DAT availability might be different between ART and TD in relation to different disease severity.

Original languageEnglish
Pages (from-to)2112-2118
Number of pages7
JournalJournal of Neurology
Volume261
Issue number11
DOIs
Publication statusPublished - 2014

Fingerprint

Dopamine Plasma Membrane Transport Proteins
Tremor
Parkinson Disease
Pharmaceutical Preparations
Putamen
Single-Photon Emission-Computed Tomography
Corpus Striatum
Hypokinesia
Disease Progression
Phenotype

Keywords

  • DAT
  • Dopamine transporter
  • Parkinson’s disease
  • SPECT

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Medicine(all)

Cite this

Moccia, M., Pappatà, S., Picillo, M., Erro, R., Coda, A. R. D., Longo, K., ... Pellecchia, M. T. (2014). Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease. Journal of Neurology, 261(11), 2112-2118. https://doi.org/10.1007/s00415-014-7459-8

Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease. / Moccia, Marcello; Pappatà, Sabina; Picillo, Marina; Erro, Roberto; Coda, Anna Rita Daniela; Longo, Katia; Vitale, Carmine; Amboni, Marianna; Brunetti, Arturo; Capo, Giuseppe; Salvatore, Marco; Barone, Paolo; Pellecchia, Maria Teresa.

In: Journal of Neurology, Vol. 261, No. 11, 2014, p. 2112-2118.

Research output: Contribution to journalArticle

Moccia, M, Pappatà, S, Picillo, M, Erro, R, Coda, ARD, Longo, K, Vitale, C, Amboni, M, Brunetti, A, Capo, G, Salvatore, M, Barone, P & Pellecchia, MT 2014, 'Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease', Journal of Neurology, vol. 261, no. 11, pp. 2112-2118. https://doi.org/10.1007/s00415-014-7459-8
Moccia, Marcello ; Pappatà, Sabina ; Picillo, Marina ; Erro, Roberto ; Coda, Anna Rita Daniela ; Longo, Katia ; Vitale, Carmine ; Amboni, Marianna ; Brunetti, Arturo ; Capo, Giuseppe ; Salvatore, Marco ; Barone, Paolo ; Pellecchia, Maria Teresa. / Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease. In: Journal of Neurology. 2014 ; Vol. 261, No. 11. pp. 2112-2118.
@article{0f401d103b2a4d21bbfe33ef03411a54,
title = "Dopamine transporter availability in motor subtypes of de novo drug-na{\"i}ve Parkinson’s disease",
abstract = "Tremor dominant (TD) and akinetic-rigid type (ART) are two motor subtypes of Parkinson’s disease associated with different disease progression and neurochemical/neuropathological features. The role of presynaptic nigrostriatal dopaminergic damage is still controversial, poorly explored, and only assessed in medicated patients. In this study, we investigated with FP-CIT SPECT the striatal dopamine transporter (DAT) availability in drug-na{\"i}ve PD patients with ART and TD phenotypes. Fifty-one de novo, drug-na{\"i}ve patients with PD underwent FP-CIT SPECT studies. Patients were evaluated with Unified Parkinson’s Disease Rating Scale (UPDRS) part III and Hoehn and Yahr scale (H&Y) and divided into ART (24/51) and TD (27/51) according to UPDRS part III. ART and TD patients were not different with regard to age, gender, and disease duration. However, compared to TD, ART patients presented higher UPDRS part III (p = 0.01) and H&Y (p = 0.02) and lower DAT availability in affected and unaffected putamen (p = 0.008 and p = 0.007, respectively), whereas no differences were found in caudate. Moreover, in the whole group of patients, rigidity and bradykinesia, but not tremor scores of UPDRS part III were significantly related to FP-CIT binding in the putamen. These results suggest that in newly diagnosed drug-na{\"i}ve PD patients DAT availability might be different between ART and TD in relation to different disease severity.",
keywords = "DAT, Dopamine transporter, Parkinson’s disease, SPECT",
author = "Marcello Moccia and Sabina Pappat{\`a} and Marina Picillo and Roberto Erro and Coda, {Anna Rita Daniela} and Katia Longo and Carmine Vitale and Marianna Amboni and Arturo Brunetti and Giuseppe Capo and Marco Salvatore and Paolo Barone and Pellecchia, {Maria Teresa}",
year = "2014",
doi = "10.1007/s00415-014-7459-8",
language = "English",
volume = "261",
pages = "2112--2118",
journal = "Journal of Neurology",
issn = "0340-5354",
publisher = "Dr. Dietrich Steinkopff Verlag GmbH and Co. KG",
number = "11",

}

TY - JOUR

T1 - Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease

AU - Moccia, Marcello

AU - Pappatà, Sabina

AU - Picillo, Marina

AU - Erro, Roberto

AU - Coda, Anna Rita Daniela

AU - Longo, Katia

AU - Vitale, Carmine

AU - Amboni, Marianna

AU - Brunetti, Arturo

AU - Capo, Giuseppe

AU - Salvatore, Marco

AU - Barone, Paolo

AU - Pellecchia, Maria Teresa

PY - 2014

Y1 - 2014

N2 - Tremor dominant (TD) and akinetic-rigid type (ART) are two motor subtypes of Parkinson’s disease associated with different disease progression and neurochemical/neuropathological features. The role of presynaptic nigrostriatal dopaminergic damage is still controversial, poorly explored, and only assessed in medicated patients. In this study, we investigated with FP-CIT SPECT the striatal dopamine transporter (DAT) availability in drug-naïve PD patients with ART and TD phenotypes. Fifty-one de novo, drug-naïve patients with PD underwent FP-CIT SPECT studies. Patients were evaluated with Unified Parkinson’s Disease Rating Scale (UPDRS) part III and Hoehn and Yahr scale (H&Y) and divided into ART (24/51) and TD (27/51) according to UPDRS part III. ART and TD patients were not different with regard to age, gender, and disease duration. However, compared to TD, ART patients presented higher UPDRS part III (p = 0.01) and H&Y (p = 0.02) and lower DAT availability in affected and unaffected putamen (p = 0.008 and p = 0.007, respectively), whereas no differences were found in caudate. Moreover, in the whole group of patients, rigidity and bradykinesia, but not tremor scores of UPDRS part III were significantly related to FP-CIT binding in the putamen. These results suggest that in newly diagnosed drug-naïve PD patients DAT availability might be different between ART and TD in relation to different disease severity.

AB - Tremor dominant (TD) and akinetic-rigid type (ART) are two motor subtypes of Parkinson’s disease associated with different disease progression and neurochemical/neuropathological features. The role of presynaptic nigrostriatal dopaminergic damage is still controversial, poorly explored, and only assessed in medicated patients. In this study, we investigated with FP-CIT SPECT the striatal dopamine transporter (DAT) availability in drug-naïve PD patients with ART and TD phenotypes. Fifty-one de novo, drug-naïve patients with PD underwent FP-CIT SPECT studies. Patients were evaluated with Unified Parkinson’s Disease Rating Scale (UPDRS) part III and Hoehn and Yahr scale (H&Y) and divided into ART (24/51) and TD (27/51) according to UPDRS part III. ART and TD patients were not different with regard to age, gender, and disease duration. However, compared to TD, ART patients presented higher UPDRS part III (p = 0.01) and H&Y (p = 0.02) and lower DAT availability in affected and unaffected putamen (p = 0.008 and p = 0.007, respectively), whereas no differences were found in caudate. Moreover, in the whole group of patients, rigidity and bradykinesia, but not tremor scores of UPDRS part III were significantly related to FP-CIT binding in the putamen. These results suggest that in newly diagnosed drug-naïve PD patients DAT availability might be different between ART and TD in relation to different disease severity.

KW - DAT

KW - Dopamine transporter

KW - Parkinson’s disease

KW - SPECT

UR - http://www.scopus.com/inward/record.url?scp=84937511607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937511607&partnerID=8YFLogxK

U2 - 10.1007/s00415-014-7459-8

DO - 10.1007/s00415-014-7459-8

M3 - Article

C2 - 25119838

AN - SCOPUS:84937511607

VL - 261

SP - 2112

EP - 2118

JO - Journal of Neurology

JF - Journal of Neurology

SN - 0340-5354

IS - 11

ER -